Verrica Pharmaceuticals (VRCA)

• Market cap: $89.9M
• 1 day: -1.06%
• 5 days: 9.13%
• 1 month: -6.8%
• 3 months: -31.8%
• 6 months: 11.29%
• Year to date: -32.29%
• 1 year: -11.77%
• 5 years: -96.73%
• 10 years: -96.79%
• Sector: Healthcare
• Industry: Biotechnology

About: Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Employees: 71